Therapeutic potential of Ampligen.
Brodsky
I
I
Department of Neoplastic Diseases, Hahnemann University School of Medicine, Philadelphia, Pennsylvania.
Strayer
D R
DR
D000386:AIDS-Related Complex / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000818:Animals; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D009369:Neoplasms / Q000188:drug therapy; D011070:Poly I-C; D011072:Poly U; D011131:Polyribonucleotides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012330:RNA, Double-Stranded / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D014410:Tumor Stem Cell Assay
D011131:Polyribonucleotides; D012330:RNA, Double-Stranded; D011072:Poly U; C047490:poly(I).poly(c12,U); D011070:Poly I-C